Zhengjun Yang, Ran Meng, Jie Ge, Chunhua Xiao, Ruixue Huang, Jianping Bai, Hong Liu, Jing Zhao, Lina Zhang, Xuchen Cao, Xin Wang. "A response-adapted and genomically informed strategy to optimize neoadjuvant chemotherapy versus endocrine therapy plus CDK4/6 inhibition in high-risk HR+/HER2− breast cancer.." Journal of Clinical Oncology (2026). https://doi.org/10.1200/jco.2026.44.16_suppl.591